EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    5.3.99.5 | Arterial Occlusive Diseases |
27511998 |
11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
3
4
0 |
| 5.3.99.5 | Carcinoma, Non-Small-Cell Lung |
24695790 |
18?-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
1
3
1 |
| 5.3.99.5 | Lung Neoplasms |
24695790 |
18?-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
1
3
1 |
| 5.3.99.5 | Pulmonary Embolism |
1311763 |
3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase. |
therapeutic application
unassigned |
1
0 |
| 5.3.99.5 | Lung Neoplasms |
20818420 |
4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A(2) and its receptor. |
causal interaction
unassigned |
3
0 |
| 5.3.99.5 | Thrombosis |
10575518 |
8th Seah Cheng Siang Memorial Lecture: new antithrombotic agents. |
therapeutic application
unassigned |
3
0 |
| 5.3.99.5 | Thrombosis |
8169831 |
A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis. |
causal interaction
therapeutic application
unassigned |
1
3
0 |
| 5.3.99.5 | Asthma |
9669829 |
A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients. |
ongoing research
unassigned |
3
0 |
| 5.3.99.5 | Hypersensitivity |
9669829 |
A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients. |
ongoing research
unassigned |
3
0 |
| 5.3.99.5 | Respiratory Distress Syndrome |
8222677 |
A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
1
2
0 |
